Please Wait
Applying Filters...
menu
    • menu
    EUROAPI, the leading small molecules API player, provides both API sales & CDMO services.

    Virtual Booth

    Contact Supplier

    SPI Pharma has been solving formulation challenges using superior functional materials.

    Virtual Booth

    Contact Supplier

    Interquim comes from an international group of 50 companies active in the pharma, hospital, diagnostics, fine chemicals & feed sectors.

    Virtual Booth

    Contact Supplier

    Cohance Lifesciences, offers full range of CDMO services for small molecule APIs, intermediates, ADCs, Pellets and Formulations.

    Virtual Booth

    Contact Supplier

    FAMAR CDMO- From early development to commercial manufacturing.

    Virtual Booth

    Contact Supplier

    Polfa Tarchomin is a leading Polish pharmaceutical company with 200 year tradition in manufacture and sale of pharmaceutical products.

    Virtual Booth

    Contact Supplier

    Menu

    Kadcyla

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Left Arrow
    Right Arrow

    Digital Content read-more

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    Genentech's Biologic Kadcyla (Trastuzumab Emtansine) Receives Approval in U.S.
    Genentech's Biologic Kadcyla (Trastuzumab Emtansine) Receives Approval in U.S.

    02 Feb 2022

    // FDA

    https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=125427

    FDA
    02 Feb 2022
    Share Share
    PhaseBio Names Jonathan Birchall as Chief Commercial Officer
    PhaseBio Names Jonathan Birchall as Chief Commercial Officer

    18 Nov 2021

    // BUSINESSWIRE

    https://www.businesswire.com/news/home/20211118006306/en

    BUSINESSWIRE
    18 Nov 2021
    Share Share
    Seagen undaunted by AstraZeneca-Daiichi's Enhertu
    Seagen undaunted by AstraZeneca-Daiichi's Enhertu

    30 Oct 2021

    // K. Dunleavy FIERCEPHARMA

    https://endpts.com/an-allergan-psychiatric-drug-failed-late-stage-depression-studies-but-abbvie-is-going-for-approval-anyway/

    K. Dunleavy FIERCEPHARMA
    30 Oct 2021
    Share Share
    AstraZeneca's Enhertu gets BTD for breast cancer; Centessa nabs $300M loan
    AstraZeneca's Enhertu gets BTD for breast cancer; Centessa nabs $300M loan

    05 Oct 2021

    // P. Schloesser ENDPTS

    https://endpts.com/astrazenecas-enhertu-gets-btd-for-breast-cancer-centessa-nabs-300m-facility-loan/

    P. Schloesser ENDPTS
    05 Oct 2021
    Share Share
    Canada's Xenon touts win for its daily epilepsy pill
    Canada's Xenon touts win for its daily epilepsy pill

    05 Oct 2021

    // P. Schloesser ENDPTS

    https://endpts.com/astrazenecas-enhertu-gets-btd-for-breast-cancer-centessa-nabs-300m-facility-loan/

    P. Schloesser ENDPTS
    05 Oct 2021
    Share Share
    AZ-Daiichi, Biogen-Samsung, Clover and more—Fierce Pharma Asia
    AZ-Daiichi, Biogen-Samsung, Clover and more—Fierce Pharma Asia

    24 Sep 2021

    // Angus Liu FIERCEPHARMA

    https://www.fiercepharma.com/pharma-asia/fierce-pharma-asia-enhertu-s-big-win-biogen-samsung-s-lucentis-biosimilar-clover-s

    Angus Liu FIERCEPHARMA
    24 Sep 2021
    Share Share